New Jersey Healthcare Blog

JULY 22, 2022

Below are the most recent health care related regulatory developments as published in the New Jersey Register in April-July 2022: April 2022. On April 4, 2022, at 54 N.J.R. On April 4, 2022, at 54 N.J.R. 290 (2022). On April 4, 2022, at 54 N.J.R. 292 (2022). On April 4, 2022, at 54 N.J.R.

COVID-19 Vaccine 40

COVID-19 Vaccine Licensing COVID-19 Public Health 40

Health Populi

MAY 28, 2023

There are some shifts we can see from the 2022 list: last year, Clorox was #3 in the top ten, with Lysol ranking second. In tomorrow’s Health Populi blog, I’ll cover the The 2003 Axios Harris Poll 100, a list of the top 100 consumer brands in the U.S. This year, Lysol ranks 4th, and Clorox fell out of the top 10.

Health Insurance 62

Health Insurance Hospitals COVID-19 62

Bill of Health

SEPTEMBER 1, 2023

The National Health Act (2003) and its accompanying regulations apply to fertility care generally, together with the guidelines that apply to reproductive health and fertility specialists. Surrogacy is specifically regulated under the Children’s Act of 2005, which sets out the legal requirements for a valid surrogacy agreement.

Health Insurance 157

Health Insurance Public Health Doctors 157

Health Law RX

JUNE 27, 2023

Earlier, in the SuperValu decision (discussed in a recent Health Law Rx Blog ), the Court clarified that subjective intent is relevant in determining whether an objectively reasonable (but incorrect) interpretation of a rule or regulation could negate the FCA’s scienter element ( U.S. 3d 250, 252 (D.C. Bayer Healthcare Pharms.,

Governance 52

Governance Fraud Compliance 52

SQA

AUGUST 8, 2023

In August 2022, ANVISA published Resolution RDC 741/2022 , which sets the framework to consider other medical device market regulators’ authorizations. The affected lots of Emerade were distributed in Canada between April 2022 and May 2023. Recalls All Lots of Emerade Epinephrine Auto-Injectors (0.3 mt and 0.5 mg and 0.5

FDA 40

FDA Compliance COVID-19 World Health 40

Drug & Device Law

APRIL 10, 2023

That’s why this defense oriented blog has inveighed against claims solely for “ medical monitoring ” ever since it was founded. 135, 156-57 (2003); Metro-North Commuter Railroad Co. 2022 WL 2274876, at *10-11 (D. June 23, 2022). 2022 WL 909406, at *3 (E.D.N.C. March 28, 2022). Prosser & P. 2007); Syms v.

Malpractice 59

Malpractice Governance Hospitals 59

Drug & Device Law

JULY 31, 2023

We have blogged several times about the somewhat esoteric issue of whether intangible items – chiefly computer software, website algorithms, and other electronic information – is treated as a “product” for purposes of imposing strict liability on their creators. 171, 212 (Fall 2022). 2003), review denied (Cal. Brown , 348 F.3d

Governance 52

Governance Payment Systems Hospitals Licensing 52